• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Can (immune and other) gene expression help us to treat depression?(免疫及其他)基因表达能帮助我们治疗抑郁症吗?
Brain Behav Immun Health. 2021 Aug 10;16:100323. doi: 10.1016/j.bbih.2021.100323. eCollection 2021 Oct.
2
Gene expression studies in Depression development and treatment: an overview of the underlying molecular mechanisms and biological processes to identify biomarkers.抑郁发生和治疗的基因表达研究:综述潜在的分子机制和生物过程,以识别生物标志物。
Transl Psychiatry. 2021 Jun 8;11(1):354. doi: 10.1038/s41398-021-01469-6.
3
A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don't work well enough?针对抑郁患者治疗抵抗的临床方法:当常规治疗效果不够好时该怎么办?
World J Biol Psychiatry. 2021 Sep;22(7):483-494. doi: 10.1080/15622975.2020.1851052. Epub 2020 Dec 8.
4
Considerations when selecting an antidepressant: a narrative review for primary care providers treating adults with depression.选择抗抑郁药时需考虑的因素:为治疗成人抑郁症的初级保健提供者提供的叙述性综述。
Postgrad Med. 2023 Jun;135(5):449-465. doi: 10.1080/00325481.2023.2189868. Epub 2023 Apr 5.
5
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
6
Glutamatergic Modulators for Major Depression from Theory to Clinical Use.用于重度抑郁症的谷氨酸能调节剂:从理论到临床应用。
CNS Drugs. 2024 Nov;38(11):869-890. doi: 10.1007/s40263-024-01114-y. Epub 2024 Aug 16.
7
A Retrospective Analysis of the Impact of Electroconvulsive Therapy on Anxiety Symptoms in Patients With Treatment-Resistant Depression.电休克治疗对难治性抑郁症患者焦虑症状影响的回顾性分析
J ECT. 2025 Jan 24. doi: 10.1097/YCT.0000000000001113.
8
The endogenous and reactive depression subtypes revisited: integrative animal and human studies implicate multiple distinct molecular mechanisms underlying major depressive disorder.再探内源性和反应性抑郁亚型:整合动物与人类研究揭示重度抑郁症背后多种不同的分子机制。
BMC Med. 2014 May 7;12:73. doi: 10.1186/1741-7015-12-73.
9
Nrf2 activation rescues stress-induced depression-like behaviour and inflammatory responses in male but not female rats.Nrf2 激活可挽救雄性但不能挽救雌性大鼠应激诱导的抑郁样行为和炎症反应。
Biol Sex Differ. 2024 Feb 13;15(1):16. doi: 10.1186/s13293-024-00589-0.
10
Individualized antidepressant therapy in patients with major depressive disorder: Novel evidence-informed decision support tool.个体化抗抑郁治疗在重性抑郁障碍患者中的应用:新型基于证据的决策支持工具。
Can Fam Physician. 2022 Nov;68(11):807-814. doi: 10.46747/cfp.6811807.

引用本文的文献

1
Multi-omic modeling of antidepressant response implicates dynamic immune and inflammatory changes in individuals who respond to treatment.抗抑郁治疗反应的多组学建模提示,对治疗有反应的个体中存在动态的免疫和炎症变化。
PLoS One. 2023 May 15;18(5):e0285123. doi: 10.1371/journal.pone.0285123. eCollection 2023.
2
Editorial commentary on the special issue emerging psychoneuroimmunology research: Future leaders in focus.关于“新兴精神神经免疫学研究:聚焦未来领袖”特刊的社论评论。
Brain Behav Immun Health. 2022 Jan 28;20:100423. doi: 10.1016/j.bbih.2022.100423. eCollection 2022 Mar.

本文引用的文献

1
Elevated C-Reactive Protein in Patients With Depression, Independent of Genetic, Health, and Psychosocial Factors: Results From the UK Biobank.抑郁症患者 C 反应蛋白升高,与遗传、健康和社会心理因素无关:来自英国生物库的结果。
Am J Psychiatry. 2021 Jun;178(6):522-529. doi: 10.1176/appi.ajp.2020.20060947. Epub 2021 May 14.
2
Augmentation therapy with minocycline in treatment-resistant depression patients with low-grade peripheral inflammation: results from a double-blind randomised clinical trial.米诺环素增强治疗抵抗性抑郁症伴低度外周炎症患者的疗效:一项双盲随机临床试验结果。
Neuropsychopharmacology. 2021 Apr;46(5):939-948. doi: 10.1038/s41386-020-00948-6. Epub 2021 Jan 28.
3
Whole-blood expression of inflammasome- and glucocorticoid-related mRNAs correctly separates treatment-resistant depressed patients from drug-free and responsive patients in the BIODEP study.全血中炎症小体和糖皮质激素相关 mRNA 的表达能正确区分 BIODEP 研究中治疗抵抗性抑郁患者与未用药和有反应患者。
Transl Psychiatry. 2020 Jul 23;10(1):232. doi: 10.1038/s41398-020-00874-7.
4
Translocator Protein 18 kDa (TSPO) Deficiency Inhibits Microglial Activation and Impairs Mitochondrial Function.18 kDa转位蛋白(TSPO)缺乏会抑制小胶质细胞活化并损害线粒体功能。
Front Pharmacol. 2020 Jun 30;11:986. doi: 10.3389/fphar.2020.00986. eCollection 2020.
5
Machine Learning Analysis of Blood microRNA Data in Major Depression: A Case-Control Study for Biomarker Discovery.机器学习分析重度抑郁症血液 microRNA 数据:用于生物标志物发现的病例对照研究。
Int J Neuropsychopharmacol. 2020 Nov 26;23(8):505-510. doi: 10.1093/ijnp/pyaa029.
6
PET imaging shows no changes in TSPO brain density after IFN-α immune challenge in healthy human volunteers.正电子发射断层扫描(PET)成像显示,在健康人类志愿者中,干扰素-α免疫挑战后 TSPO 脑密度没有变化。
Transl Psychiatry. 2020 Mar 9;10(1):89. doi: 10.1038/s41398-020-0768-z.
7
A Machine Learning Approach to Identify a Circulating MicroRNA Signature for Alzheimer Disease.一种用于鉴定阿尔茨海默病的循环 microRNA 特征的机器学习方法。
J Appl Lab Med. 2020 Jan 1;5(1):15-28. doi: 10.1373/jalm.2019.029595.
8
Novel neuroimmunologic therapeutics in depression: A clinical perspective on what we know so far.新型神经免疫治疗在抑郁症中的应用:目前我们所了解的临床观点。
Brain Behav Immun. 2020 Jan;83:7-21. doi: 10.1016/j.bbi.2019.09.016. Epub 2019 Sep 21.
9
The TSPO Ligands 2-Cl-MGV-1, MGV-1, and PK11195 Differentially Suppress the Inflammatory Response of BV-2 Microglial Cell to LPS.TSPO 配体 2-Cl-MGV-1、MGV-1 和 PK11195 对 LPS 诱导的 BV-2 小胶质细胞炎症反应的抑制作用存在差异。
Int J Mol Sci. 2019 Jan 30;20(3):594. doi: 10.3390/ijms20030594.
10
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家层面 195 个国家和地区 1990 年至 2017 年 354 种疾病和伤害导致的发病率、患病率和伤残损失寿命年:基于 2017 年全球疾病负担研究的系统分析。
Lancet. 2018 Nov 10;392(10159):1789-1858. doi: 10.1016/S0140-6736(18)32279-7. Epub 2018 Nov 8.

(免疫及其他)基因表达能帮助我们治疗抑郁症吗?

Can (immune and other) gene expression help us to treat depression?

作者信息

Mariani Nicole

机构信息

Stress, Psychiatry and Immunology Laboratory, Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, UK.

出版信息

Brain Behav Immun Health. 2021 Aug 10;16:100323. doi: 10.1016/j.bbih.2021.100323. eCollection 2021 Oct.

DOI:10.1016/j.bbih.2021.100323
PMID:34514441
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7611633/
Abstract

It is becoming clearer that it might be a combination of different biological processes such as genetic, environmental, and psychological factors, together with immune system, stress response, brain neuroplasticity and the regulation of neurotransmitters, that leads to the development of major depressive disorder (MDD). A growing number of studies have tried to investigate the underlying mechanisms of MDD by analysing the expression levels of genes (mRNA) involved in such biological processes. In this review, I have highlighted a possible key role that gene expression might play in the treatment of MDD. This is critical because many patients do not respond to antidepressant treatment or can experience side effects, causing treatment to be interrupted. Unfortunately, selecting the best antidepressant for each individual is still largely a matter of making an informed guess.

摘要

越来越清楚的是,可能是遗传、环境和心理因素等不同生物过程,连同免疫系统、应激反应、大脑神经可塑性以及神经递质的调节,共同导致了重度抑郁症(MDD)的发生。越来越多的研究试图通过分析参与此类生物过程的基因(mRNA)表达水平来探究MDD的潜在机制。在这篇综述中,我强调了基因表达可能在MDD治疗中发挥的关键作用。这一点至关重要,因为许多患者对抗抑郁治疗无反应或会出现副作用,导致治疗中断。不幸的是,为每个个体选择最佳抗抑郁药在很大程度上仍然只是一种有根据的猜测。